Controversial Alzheimer’s Drug Trial Stopped Due to Disappointing Outcome

Cassava Sciences reported that their medication did not show a significant reduction in cognitive decline among 1,900 individuals with mild to moderate Alzheimer’s disease.
Cassava Sciences reported that their medication did not show a significant reduction in cognitive decline among 1,900 individuals with mild to moderate Alzheimer’s disease.